Cargando…
Vibegron 50 mg Once Daily Improves OABSS, OAB-q SF Score in OAB Patients ≥80 Years Old in Real-World Clinical Settings and Switching from Other OAB Drugs May Reduce Residual Urine Volume
OBJECTIVE: The treatment effects of vibegron have not previously been evaluated in a prospective, non-interventional observational study of elderly Japanese patients, particularly those ≥80 years old. In addition, no reports have referred to residual urine volume in switching cases. We therefore gro...
Autores principales: | Kuno, Takahira, Tamura, Kenji, Shimizu, Nobutaka, Fukuhara, Hideo, Fukata, Satoshi, Ashida, Shingo, Karashima, Takashi, Satake, Hirofumi, Sawada, Kohji, Yamasaki, Ichiro, Komatsu, Fumito, Kuroiwa, Hajime, Saito, Motoaki, Inoue, Keiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216872/ https://www.ncbi.nlm.nih.gov/pubmed/37251707 http://dx.doi.org/10.2147/RRU.S411841 |
Ejemplares similares
-
Plain language summary: does treatment with vibegron result in improvements in overactive bladder (OAB) symptoms that are meaningful to people with OAB?
por: Frankel, Jeffrey, et al.
Publicado: (2023) -
AB33. Botox: the novel therapy for OAB
por: Deng, Donna
Publicado: (2014) -
Urine Proteomic Study in OAB Patients—Preliminary Report
por: Futyma, Konrad, et al.
Publicado: (2020) -
The emperor has no clothes: OAB can be cured surgically
por: Petros, Peter
Publicado: (2022) -
Development of a core set of outcome measures for OAB treatment
por: Foust-Wright, Caroline, et al.
Publicado: (2017)